Image

Research of Biomarkers Associated With the Diagnosis and Severity of Bradykinin Angioedema

Research of Biomarkers Associated With the Diagnosis and Severity of Bradykinin Angioedema

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The unpredictable nature of the attacks is one of the essential characteristics of bradykinin angioedema. The two main difficulties for physicians managing a patient with bradykinin angioedema are to make the diagnosis and anticipate the severity.

Biomarkers can be used to diagnose, guide treatment, or predict the severity of a disease. However, the identification of biomarkers is currently difficult in bradykinin both for diagnosis and prognosis. While measurement of C4 and C1 inhibitor (quantitative and functional assays) allows the diagnosis of bradykinin angioedema due to C1 inhibitor deficiency, whether genetic or acquired, many patients with normal C1 inhibitor bradykinin angioedema, either hereditary or acquired, are still difficult to diagnose. For patients with hereditary angioedema with C1-inhibitor deficiency, there is no biomarker currently available to predict the severity. Any biomarker that could improve the diagnosis on the one hand, and improve the prediction of the frequency and severity of the response to treatment on the other hand, would obviously be extremely useful. The aim of our study is to assess the existence possible biomarkers for diagnosis and prognosis of bradykinin angioedema.

Eligibility

Inclusion Criteria:

  • Group 1 : Patients with bradykinin angioedema
  • Patient with biologically proven hereditary angioedema with C1 inhibitor deficiency,
  • Or a patient with bradykinin angioedema related to a plasminogen or factor XII mutation,
  • Or patients with bradykinin angioedema related to ACE inhibitors or ARB2,
  • Or patient with acquired bradykinin angioedema due to C1 inhibitor deficiency,
  • Age > or = 18 years with the capacity to understand the requirements of the study and to give a non-opposition
  • Having a blood collection scheduled as part of routine care
  • Being insured by social security

Group 2 : Patients with histamine-mediated angioedema

  • Patient with idiopathic histamine angioedema as determined by the referring physician
  • Age > or = 18 years with the capacity to understand the requirements of the study and to give a non-opposition
  • Having a blood collection scheduled as part of routine care
  • Being insured by social security

Exclusion Criteria:

  • Minors or protected adults,
  • Pregnant or breastfeeding woman,
  • Person deprived of liberty,
  • Person in an emergency situation,
  • Person having refused or unable to give their non-opposition

Study details
    Angio Edema

NCT04963634

University Hospital, Lille

27 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.